← Back to Search

Quality Improvement Intervention for Liver Cirrhosis

N/A

Waitlist Available

Led By Shari S Rogal, MD MPH

Research Sponsored by VA Office of Research and Development

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up those who have had a variceal screening done in the past 3.5 years.

Awards & highlights

Study Summary

This trial will help determine which strategies work best for improving care for Veterans with cirrhosis.

Who is the study for?

This trial is specifically for veterans diagnosed with cirrhosis or advanced liver disease who are receiving care within the Veterans Affairs (VA) healthcare system.Check my eligibility

What is being tested?

The study is testing quality improvement interventions. It seeks to identify which data-driven strategies can best enhance evidence-based practices for high-quality cirrhosis care among veterans.See study design

What are the potential side effects?

Since this trial focuses on quality improvement rather than a medical treatment, it does not involve typical medication side effects. However, changes in care procedures may affect patient experience.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ those who have had a variceal screening done in the past 3.5 years.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~those who have had a variceal screening done in the past 3.5 years.

This trial's timeline: 3 weeks for screening, Varies for treatment, and those who have had a variceal screening done in the past 3.5 years. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Screening procedure

Screening for varices

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Quality Improvement InterventionExperimental Treatment1 Intervention

Twelve low-performing sites will receive a package of strategies which have been empirically determined to be associated with successful implementation of evidence based practices that lead to improved health outcomes for Veterans with cirrhosis.

Group II: Control ArmActive Control1 Intervention

All sites besides the pre-selected twelve, a total of one hundred eighteen sites, will not receive the intervention and will provide care as usual.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

VA Pittsburgh Healthcare SystemFED

32 Previous Clinical Trials

11,397 Total Patients Enrolled

VA Office of Research and DevelopmentLead Sponsor

1,609 Previous Clinical Trials

3,306,591 Total Patients Enrolled

3 Trials studying Liver Cirrhosis

330 Patients Enrolled for Liver Cirrhosis

Shari S Rogal, MD MPHPrincipal InvestigatorVA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA

1 Previous Clinical Trials

8,020 Total Patients Enrolled

Media Library

Quality Improvement Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04178096 — N/A

Liver Cirrhosis Research Study Groups: Control Arm, Quality Improvement Intervention

Liver Cirrhosis Clinical Trial 2023: Quality Improvement Intervention Highlights & Side Effects. Trial Name: NCT04178096 — N/A

Quality Improvement Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04178096 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the current recruitment criteria for this clinical research?

"Information accessible on clinicaltrials.gov deduces that enrollment for this trial has concluded, as the last update was made on February 14th 2022. Despite being unable to participate in this particular study, 465 other trials are still recruiting interested participants at present."

Answered by AI

Recent research and studies

Implementation ScienceJournal

Getting to Implementation: A Protocol for a Hybrid III Stepped Wedge Cluster Randomized Evaluation of Using Data-driven Implementation Strategies to Improve Cirrhosis Care for Veterans

Rogal, Shari S., Vera Yakovchenko, Timothy Morgan, Jasmohan S. Bajaj, Rachel Gonzalez, Angela Park, Lauren Beste, et al.. 2020. “Getting to Implementation: A Protocol for a Hybrid III Stepped Wedge Cluster Randomized Evaluation of Using Data-driven Implementation Strategies to Improve Cirrhosis Care for Veterans”. Implementation Science. Springer Science and Business Media LLC. doi:10.1186/s13012-020-01050-7.

clinicaltrials.govStudy

Using Data-Driven Implementation Strategies to Improve the Quality of Cirrhosis Care

2019. "Using Data-Driven Implementation Strategies to Improve the Quality of Cirrhosis Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04178096.